In uveal melanoma and myelodysplastic syndrome, SF3B1 mutations are associated with a better prognosis, whereas in CLL, SF3B1 mutations are correlated with a worse prognosis [17, 20, 40, 41]. This evidence concerns the gene SF3B1 and uveal melanoma.